Maria G Vogiatzi, M.D.
Professor of Pediatrics (Endocrinology and Diabetes) at the Children's Hospital of Philadelphia
Attending Physician, Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia
Founder/Director, Adrenal and Puberty Center, Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Endocrinology and Diabetes
Philadelphia, PA 19104
Division of Endocrinology and Diabetes
Philadelphia, PA 19104
Office: 215-590-3174
Email:
vogiatzim@chop.edu
vogiatzim@chop.edu
Publications
Links
Search PubMed for articles
Page on CHOP research institute describing Dr Vogiatzi's research profile
Page describing the CHOP adrenal and puberty center.
Search PubMed for articles
Page on CHOP research institute describing Dr Vogiatzi's research profile
Page describing the CHOP adrenal and puberty center.
Education:
M.D. (Medicine )
Medical School of Aristotelian University, Thessaloniki, Greece , 1987.
Permanent linkM.D. (Medicine )
Medical School of Aristotelian University, Thessaloniki, Greece , 1987.
Description of Clinical Expertise
Dr Vogiatzi is a Pediatric Endcornologist. She leads subspecialty programs for patients and families with Congenital Adrenal Hyperplasia (CAH), Klinefelter syndrome and all other Differences of Sex Development (DSD). Her clinical practice also focuses in the diagnosis and management of children with adrenal insufficiency, disorders of puberty and hypogonadism. She also runs an inpatient consult service focused on adrenal disorders.Description of Research Expertise
Dr Vogiatzi's research interests including studies in CAH, sex aneuploidies and the effect of sex steroids on health and disease.Selected Publications
Jafar B, Kilberg MJ, Vogiatzi MG.: Delayed Diagnosis of Classic Congenital Adrenal Hyperplasia Secondary to False-Negative Newborn Screening Results. J Pediatr. 283: 114597, Apr 16 2025 Notes: doi: 10.1016/j.jpeds.2025.114597.Dayno A, Kilberg MJ, Vogiatzi MG. : Mineralocorticoid Defects in Children. Endotext [Internet]. Muzumdar R, Sperling MA, editors. (eds.). MDText.com, April 20 2025.
Hall A, Furniss A, Tartaglia NN, Janusz J, Wilson R, Middleton C, Martin S, Frazier J, Martinez-Chadrom M, Hansen-Moore J, Ikomi C, Ross J, Vogiaski MG, Morrow L, Christakis DA, Lean RE, Nokoff N, Pyle L, Davis SM. : Neurodevelopmental and Mental Health Outcomes in a National Clinical Sample of Youth With Sex Chromosome Trisomies Compared With Matched Controls. J Dev Behav Pediatr. 46(2): e208-e215, Mar-Apr 01 2025 Notes: doi: 10.1097/DBP.0000000000001342. Epub 2025 Jan 9.
Chen LM, Valentine A, Davis SM, Graber E, Fechner PY, Furniss A, Nahata L, Pyle L, Vyas AK, Vogiatzi MG, Nokoff NJ. : Multicenter Analysis of Cardiometabolic-Related Diagnoses in Youth With Congenital Adrenal Hyperplasia: A PEDSnet Study. J Clin Endocrinol Metab. 110(4): e1009-e1016, March 17 2025 Notes: doi: 10.1210/clinem/dgae362.
Kilberg MJ and Vogiatzi MG: Congenital Adrenal Hyperplasia BMJ best practice 2025.
Kilberg MJ, Vogiatzi MG. : Adrenal Insufficiency in Children. Endotext [Internet] Muzumdar R, Sperling MA, editors. (eds.). MDText.com, Inc. Oct 2 2024.
uchus RJ, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel SF, Isidori AM, Rodien P, Srirangalingam U, Kiefer FW, Falhammar H, Merke DP, Reisch N, Sarafoglou K, Cutler GB Jr, Sturgeon J, Roberts E, Lin VH, Chan JL, Farber RH; CAHtalyst Adult Trial Investigators. : A Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. N Engl J Med. 391(6): 504-514, Aug 8 2024 Notes: doi: 10.1056/NEJMoa2404656. Epub 2024 Jun 1.
Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, Clemente M, Fechner PY, Vogiatzi MG, Speiser PW, Auchus RJ, Rosales GBG, Roberts E, Jeha GS, Farber RH, Chan JL; CAHtalyst Pediatric Trial Investigators.: Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia. N Engl J Med. 391(6): 493-503, Aug 8 2024.
Lisanti AJ, Dong F, Demianczyk A, Vogiatzi MG, Quinn R, Chittams J, Hoffman R, Medoff Cooper B. : Salivary Diurnal Cortisol Predicts Post-Traumatic Stress Symptoms in Parents of Infants With Congenital Heart Disease. Biol Res Nurs. Page: doi: 10.1177/10998004231224791. Epub ahead of print. Jan 2024.
Newfield RS, Sarafoglou K, Fechner PY, Nokoff NJ, Auchus RJ, Vogiatzi MG, Jeha GS, Giri N, Roberts E, Sturgeon J, Chan JL, Farber RH.: Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 108(11): 2871-2878, Oct 18 2023 Notes: doi: 10.1210/clinem/dgad270.